Diet study for early-stage CLL
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether a whole-food plant-based diet for 4 weeks can affect immune function and metabolism in people with early-stage CLL who have not yet had treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with CLL and have not had any treatment yet
- You are willing to follow a whole-food plant-based diet for 4 weeks (no meat, dairy, eggs, or processed foods)
- You are willing to give blood samples three times during the study
- You are not already following a vegan or plant-based diet
- You do not have insulin-dependent diabetes
- You are not taking medications like statins for cholesterol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study looks at how chronic lymphocytic leukemia (CLL) cells use energy in lymph nodes. It may help find new ways to treat CLL in the future.
This study tests whether eating a strict whole-foods, plant-based diet can help people with breast or endometrial cancer. It looks at how the diet affects cancer and overall health.
This trial studies whether limiting when you eat each day (time-restricted eating) can help people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It compares their response to people without cancer who follow the same eating pattern.
This study looks at real-world experiences of people with chronic lymphocytic leukemia (CLL) who have used or are using a type of targeted therapy called a BCL-2 inhibitor. It aims to understand how well these treatments work and their side effects in everyday practice.
Hear when a new CLL (Chronic Lymphocytic Leukemia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.